<DOC>
	<DOCNO>NCT02911870</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial evaluate effect SNAC cardiac repolarisation healthy male subject</brief_summary>
	<brief_title>A Thorough QTc Trial Evaluating Effect SNAC Cardiac Repolarisation Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Male age 1855 year ( inclusive ) time sign informed consent Body mass index ( BMI ) 18.5âˆ’28.0 kg/m^2 ( inclusive ) Considered generally healthy base medical history , physical examination , result vital sign clinical laboratory test perform screen visit , judge investigator Normal electrocardiogram ( ECG ) screen minor finding consider clinically significant , judged investigator Smoker ( define subject smoke 5 cigarette equivalent per week ) , subject smoke equal le 5 cigarette equivalent per week able willing refrain smoking use nicotine substitute product within 48 hour prior dose inpatient period Any blood draw excess 25 mL past month , donation blood plasma excess 400 mL within 3 month precede screen Sitting blood pressure screening ( rest least 5 minute ) outside range 90139 mmHg systolic 5089 mmHg diastolic History major surgical procedure involve stomach potentially affect absorption trial product ( e.g . subtotal total gastrectomy , sleeve gastrectomy , gastric bypass surgery )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>